Breast cancer versus hormone therapy of the menopausal period

Tomasz Pertyński; Grzegorz Stachowiak

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

3/2005
vol. 4

Send email

Copy url:

abstract:

Breast cancer versus hormone therapy of the menopausal period

Tomasz Pertyński

,

Grzegorz Stachowiak

Prz Menopauz 2005; 3: 47–52

Online publish date: 2005/06/09

View full text Get citation

In this article some data on the connection between sex steroids and mammary gland development, mitosis, apoptosis as well as cancerogenesis in the mamma have been presented. Also the newest information about the safety of hormone therapy in the group of breast cancer survivors has been quoted. Being of opinion that at present only estrogens are able to treat climacteric symptoms completely, the authors are sharing their opinion about an important role to be played in menopause by the well-tailored, low-dose (25 mg and 37,5 μg 17β-E₂/day), transdermal estrogen therapy.

keywords:

Breast cancer versus hormone therapy of the menopausal period

Tomasz Pertyński , Grzegorz Stachowiak

breast cancer, menopause, estrogens, transdermal hormone therapy

Tomasz Pertyński

,

Grzegorz Stachowiak